Found: 24
Select item for more details and to access through your institution.
Synthetic approaches to site selective deuterium incorporation in a novel CRTh2 receptor antagonist clinical candidate.
- Published in:
- 2014
- By:
- Publication type:
- Other
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 306, doi. 10.1002/cpdd.244
- By:
- Publication type:
- Article
Prostaglandin D<sub>2</sub> metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP<sub>2</sub> receptor.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The prostaglandin D<sub>2</sub> receptor 2 pathway in asthma: a key player in airway inflammation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Editorial.
- Published in:
- Communications Engineer, 2007, v. 5, n. 6, p. 2, doi. 10.1049/ce:20070601
- By:
- Publication type:
- Article
Editorial.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Editorial and Letters to the Editor.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Editor's letter.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Editor's letter.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
New Books.
- Published in:
- 2007
- By:
- Publication type:
- Book Review
Editor's letter.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
A revolution in the making? [WiMax standards].
- Published in:
- Communications Engineer, 2006, v. 4, n. 5, p. 22, doi. 10.1049/ce:20060503
- By:
- Publication type:
- Article
Editor's letter.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Editor's letter.
- Published in:
- Communications Engineer, 2006, v. 4, n. 4, p. 2, doi. 10.1049/ce:20060410
- By:
- Publication type:
- Article
Editor's letter.
- Published in:
- Communications Engineer, 2006, v. 4, n. 3, p. 2, doi. 10.1049/ce:20060308
- By:
- Publication type:
- Article
Will viruses leap to mobiles?
- Published in:
- Communications Engineer, 2006, v. 4, n. 2, p. 24, doi. 10.1049/ce:20060203
- By:
- Publication type:
- Article
What next for mobile TV?
- Published in:
- Communications Engineer, 2006, v. 4, n. 2, p. 10, doi. 10.1049/ce:20060210
- By:
- Publication type:
- Article
Connect the world.
- Published in:
- Communications Engineer, 2006, v. 4, n. 2, p. 2
- By:
- Publication type:
- Article
Editor's letter.
- Published in:
- Communications Engineer, 2006, v. 4, n. 1, p. 2, doi. 10.1049/ce:20060107
- By:
- Publication type:
- Article
Gadgets.
- Published in:
- 2005
- By:
- Publication type:
- Product Review
Will the cars of the future dream of electric sheep?
- Published in:
- 2005
- By:
- Publication type:
- Editorial
A forum for debate.
- Published in:
- 2005
- By:
- Publication type:
- Book Chapter
Studies on high-temperature amination reactions of aromatic chlorides using discrete Palladium- N-Heterocyclic Carbene (NHC) complexes and in situ palladium/imidazolium salt protocols.
- Published in:
- Molecular Diversity, 2003, v. 7, n. 2-4, p. 115, doi. 10.1023/B:MODI.0000006863.14423.da
- By:
- Publication type:
- Article
Fevipiprant, a DP<sub>2</sub> receptor antagonist, inhibits eosinophil migration towards mast cells.
- Published in:
- Clinical & Experimental Allergy, 2019, v. 49, n. 2, p. 255, doi. 10.1111/cea.13304
- By:
- Publication type:
- Article